DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,037,541 | +21.7% | 870,768 | +17.7% | 0.26% | +29.7% |
| Q2 2023 | $177,572,640 | -35.7% | 739,886 | -32.5% | 0.20% | -39.3% |
| Q1 2023 | $276,196,522 | -20.0% | 1,095,844 | -15.8% | 0.33% | -21.8% |
| Q4 2022 | $345,348,844 | +2.2% | 1,301,141 | +0.9% | 0.43% | +0.7% |
| Q3 2022 | $337,965,000 | -0.7% | 1,289,205 | -3.9% | 0.42% | +7.4% |
| Q2 2022 | $340,245,000 | -14.7% | 1,342,081 | -1.3% | 0.39% | +7.9% |
| Q1 2022 | $398,703,000 | -16.5% | 1,359,230 | -6.3% | 0.36% | -8.8% |
| Q4 2021 | $477,471,000 | +43.3% | 1,451,237 | +32.6% | 0.40% | +15.6% |
| Q3 2021 | $333,225,000 | +2.5% | 1,094,553 | +0.1% | 0.35% | +4.8% |
| Q2 2021 | $325,223,000 | +38.3% | 1,093,222 | +4.6% | 0.33% | +25.5% |
| Q1 2021 | $235,132,000 | -1.5% | 1,044,658 | -2.8% | 0.26% | -9.3% |
| Q4 2020 | $238,717,000 | -1.2% | 1,074,623 | -4.3% | 0.29% | -13.4% |
| Q3 2020 | $241,681,000 | +3.6% | 1,122,375 | -14.9% | 0.34% | +0.9% |
| Q2 2020 | $233,272,000 | +25.1% | 1,319,185 | -2.1% | 0.33% | +5.1% |
| Q1 2020 | $186,496,000 | -20.9% | 1,347,417 | -12.3% | 0.32% | -7.6% |
| Q4 2019 | $235,897,000 | -4.9% | 1,536,989 | -10.5% | 0.34% | -9.8% |
| Q3 2019 | $248,013,000 | -0.5% | 1,717,183 | -1.6% | 0.38% | +1.6% |
| Q2 2019 | $249,288,000 | +7.7% | 1,744,246 | -0.5% | 0.37% | +5.7% |
| Q1 2019 | $231,382,000 | +35.6% | 1,752,628 | +5.9% | 0.35% | +18.9% |
| Q4 2018 | $170,617,000 | -6.9% | 1,654,546 | -1.9% | 0.30% | +9.6% |
| Q3 2018 | $183,288,000 | +7.5% | 1,686,804 | -2.4% | 0.27% | +4.2% |
| Q2 2018 | $170,513,000 | -10.6% | 1,727,931 | -11.3% | 0.26% | -11.0% |
| Q1 2018 | $190,825,000 | +6.0% | 1,948,981 | +0.5% | 0.29% | +11.5% |
| Q4 2017 | $179,965,000 | +4.8% | 1,938,855 | -3.2% | 0.26% | +1.9% |
| Q3 2017 | $171,737,000 | +0.9% | 2,002,063 | -0.7% | 0.26% | -4.1% |
| Q2 2017 | $170,139,000 | -9.4% | 2,016,110 | -8.2% | 0.27% | -10.7% |
| Q1 2017 | $187,835,000 | +11.1% | 2,196,133 | +1.2% | 0.30% | +5.3% |
| Q4 2016 | $168,993,000 | +26.9% | 2,171,028 | +27.8% | 0.28% | +23.9% |
| Q3 2016 | $133,209,000 | -21.4% | 1,699,307 | +1.2% | 0.23% | -25.1% |
| Q2 2016 | $169,520,000 | +8.6% | 1,678,408 | +2.0% | 0.31% | +5.1% |
| Q1 2016 | $156,148,000 | -20.4% | 1,646,086 | -22.1% | 0.29% | -24.9% |
| Q4 2015 | $196,279,000 | +3.1% | 2,113,254 | -5.4% | 0.39% | +3.7% |
| Q3 2015 | $190,314,000 | +14.1% | 2,233,466 | +14.6% | 0.38% | +25.8% |
| Q2 2015 | $166,838,000 | +37.7% | 1,949,274 | +36.6% | 0.30% | +36.1% |
| Q1 2015 | $121,131,000 | +0.2% | 1,426,751 | +1.2% | 0.22% | +8.4% |
| Q4 2014 | $120,885,000 | +21.6% | 1,410,394 | +7.8% | 0.20% | +17.4% |
| Q3 2014 | $99,445,000 | -0.8% | 1,308,826 | +2.8% | 0.17% | +0.6% |
| Q2 2014 | $100,214,000 | +10.3% | 1,272,884 | +5.0% | 0.17% | +3.6% |
| Q1 2014 | $90,882,000 | +6.0% | 1,211,749 | +9.1% | 0.16% | +3.1% |
| Q4 2013 | $85,742,000 | +6.2% | 1,110,649 | -4.7% | 0.16% | 0.0% |
| Q3 2013 | $80,760,000 | +10.3% | 1,165,034 | +0.8% | 0.16% | +1.9% |
| Q2 2013 | $73,191,000 | – | 1,156,266 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |